---
schema_version: "secwatch.filing_event.v1"
accession: "0001398733-25-000020"
form_type: "8-K"
ticker: "AQST"
cik: "0001398733"
company_name: "Aquestive Therapeutics, Inc."
filed_at: "2025-10-01T23:59:59+00:00"
generated_at: "2026-05-17T05:04:09.617693+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Aquestive Therapeutics furnishes October 2025 investor presentation

## Summary
- Presentation includes company overview, pipeline, and strategy; no new financial results disclosed.
- Filed under Regulation FD as a routine investor presentation for institutional meetings.
- No specific material changes or guidance updates noted in the exhibit text provided.

## SEC filing metadata
- accession: 0001398733-25-000020
- form_type: 8-K
- ticker: AQST
- cik: 0001398733
- company_name: Aquestive Therapeutics, Inc.
- filed_at: 2025-10-01T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1398733/000139873325000020/0001398733-25-000020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1398733/000139873325000020/aqst-20251001.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001398733-25-000020
- JSON: https://secwatch.observer/filing/0001398733-25-000020.json
- Plain text: https://secwatch.observer/filing/0001398733-25-000020.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.